Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has provided an update.
Proteomics International Laboratories Ltd has announced the appointment of Tim Luscombe as the new Company Secretary, succeeding Karen Logan who has resigned after ten years of service. Luscombe, who brings over a decade of finance and commercial experience, will enhance the company’s communications with the ASX, potentially strengthening its operational efficiency and market positioning in the healthcare sector.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, based in Perth, Western Australia, is a medical technology company specializing in precision diagnostics and bio-analytical services, focusing on the industrial-scale study of proteomics to improve disease treatment.
YTD Price Performance: -17.50%
Average Trading Volume: 137,124
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$86.46M
See more data about PIQ stock on TipRanks’ Stock Analysis page.
